AI, Anthropic and Mythos
Digest more
Anthropic CEO Dario Amodei met White House Chief of Staff Susie Wiles as the government reacts to its Mythos system that automates some of the work of cyberattacks.
That human-accountable model makes the most sense to me. By all means, integrate AI into the systems employees already use and let it take over the repetitive, time-consuming drudgery of the job. But we still need someone to vet the results and decide whether it makes sense.
Following its recently announced partnership with Novo Nordisk, OpenAI is introducing a new reasoning model, GPT-Rosalind, to support research in biology, drug discovery and translational medicine. | Following its recently announced partnership with Novo Nordisk,
By Juby Babu April 16 - OpenAI on Thursday introduced an artificial intelligence model touting increased biology knowledge and scientific research capabilities, as the startup deepens its push into the life sciences field.
OpenAI is rolling out an early version of an artificial intelligence model meant to speed up drug discoveries, joining a field of growing interest for tech companies eager to prove AI can pave the way for more scientific breakthroughs.
Morning Overview on MSN
OpenAI rolls out cyber-focused model as fears grow over AI-aided hacking
OpenAI has released an AI model built specifically to help cybersecurity professionals detect and fix software vulnerabilities, entering a market where the line between digital defense and digital offense is razor-thin.
Muse Spark, as what Meta Platforms (NASDAQ:META | META Price Prediction) is calling its much-anticipated closed-source model, which used to go by the codename Avocado. Undoubtedly, it’s an interesting name,
Quantum stocks climbed on Thursday, adding to a massive week-to-date rally fueled by enthusiasm for Nvidia 's new open-source artificial intelligence models designed to advance the burgeoning computing technology.
OpenAI's latest AI model is built to do far more than offer cooking advice or create a spreadsheet. GPT-Rosalind, the company's first model specifically built for life science, is meant to help scientists with drug discovery, biology and translational medicine.